{"count": 1, "results": [{"_id": "26041263", "pmid": 26041263, "title": "How do changes in the mtDNA and mitochondrial dysfunction influence cancer and cancer therapy? Challenges, opportunities and models.", "journal": "Mutat Res Rev Mutat Res", "authors": ["van Gisbergen MW", "Voets AM", "Starmans MH", "de Coo IF", "Yadak R", "Hoffmann RF", "Boutros PC", "Smeets HJ", "Dubois L", "Lambin P"], "date": "2015-04-01T00:00:00Z", "doi": "10.1016/j.mrrev.2015.01.001", "meta_date_publication": "2015 Apr-Jun", "meta_volume": "764", "meta_issue": "", "meta_pages": "16-30", "score": 50038.68, "text_hl": "Pharmaceutical impairment of @<m>DISEASE_CoQ_responsive_OXPHOS_deficiency</m> @DISEASE_MESH:C535470 @@@OXPHOS@@@ by @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ can increase the efficiency of radiotherapy. ", "citations": {"NLM": "van Gisbergen MW, Voets AM, Starmans MH, de Coo IF, Yadak R, Hoffmann RF, Boutros PC, Smeets HJ, Dubois L, Lambin P. How do changes in the mtDNA and mitochondrial dysfunction influence cancer and cancer therapy? Challenges, opportunities and models. Mutat Res Rev Mutat Res. 2015 Apr-Jun;764():16-30. PMID: 26041263", "BibTeX": "@article{26041263, title={How do changes in the mtDNA and mitochondrial dysfunction influence cancer and cancer therapy? Challenges, opportunities and models.}, author={van Gisbergen MW and Voets AM and Starmans MH and de Coo IF and Yadak R and Hoffmann RF and Boutros PC and Smeets HJ and Dubois L and Lambin P}, journal={Mutat Res Rev Mutat Res}, volume={764}, pages={16-30}}"}}]}